Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hetlioz Pill

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Tasimelteon (Hetlioz®) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non… Expand
  • table 1
Is this relevant?
Review
2015
Review
2015
Tasimelteon (Hetlioz®), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be… Expand
Is this relevant?